---------------------------------
The Pharmacist e-Link™ Continuing Education Center is designed to provide you with expanded online access to the highest quality of continuing education on a complimentary basis, through the convenience of the Velocity™ Online Learning Management System. |
---------------------------------
---------------------------------
Need Help logging into the Pharmacicst e-Link site?
Click Here for Registration and
Login Information
---------------------------------
 |
| |
 |
 Pharmacist e-Link CE Spotlight |
 |
 |
Implementing a Successful Pharmacy Immunization Program
From planning, to execution and marketing, this program by a pharmacy peer, will walk the community pharmacy practitioner through the process of implementing an immunization niche in their community pharmacy.
Commercial Support Provided by Novartis Vaccines.
|
|
The Medication Therapy Management of Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of death in America. Pharmacists are key team members caring for COPD patients and have a huge opportunity to manage the medication therapy of these patients, including counseling and continually reinforcing the importance of adherence to these medicines.
Commercial Support Provided by Boehringer Ingelheim. |
|
Optimizing Patient Outcomes in Asthma
This program will review current guidelines for the assessment and treatment of asthma and will discuss strategies to evaluate and enhance treatment adherence. Recent clinical trials and their potential impact on clinical practice will also be discussed.
This activity is funded through an educational grant from AstraZeneca Pharmaceuticals LP. |
|
Practical Approaches to Managing the High-Risk Patient with Complex Dyslipidemia
The program begins with the presentation of a complex case of dyslipidemia, in which the patient has normal LDL cholesterol levels. Following a presentation on the epidemiology of dyslipidemia, emerging data on surrogate markers such as apoC-III, CRP, LpPLA2 and Lp(a) are presented.
This educational activity is supported by an unrestricted grant from Reliant Pharmaceuticals. |
|
|
